KalVista Pharmaceuticals, Inc.

KALVNASDAQHealthcare● Active

$26.98

+$0.03(+0.11%)

Market Cap$1.4B

P/E Ratio—

52W High$26.98

52W Low$9.83

Avg Volume3.4M

Open$26.97

Beta-0.11

Insider Trades Ownership Employees

KalVista Pharmaceuticals, Inc.（KALV）内幕交易

基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。

SEC EDGAR · FMP · KALV · 截至 2026年6月8日

活动摘要

买入笔数

P-Purchase only

卖出笔数

近12个月

买卖比

0.00

Buy/Sell (by trades)

整体情绪

偏空

↑ Buy 0%仅显示有效交易 · 排除RSU归属100% Sell ↓

KalVista Pharmaceuticals, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。

▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale

截至 2026年6月8日

KALV 季度内部人买卖趋势

KALV 内幕交易卖出 · KALV 内幕交易买入 · 季度活动

买入总量（含股权归属）卖出总量

992K496K0

2024 Q3

2024 Q4

2025 Q1

2025 Q2

2025 Q3

2025 Q4

2026 Q1

2026 Q2

Mobile shows last 4Q · Desktop shows full 8Q

▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度

As of Jun 8, 2026

活跃内部人

近12个月交易最活跃 · KALV CEO内幕交易

显示全部内部人 · 点击卡片过滤下方交易表

▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API

近期内幕交易记录

KALV 高管卖出股份 · KALV 董事内幕交易 · SEC Form 4申报

显示最近 64 条 · 普通股 · 仅Form 4

横向滑动查看全部列

日期	内部人	类型	股数	均价	总金额	交易后持股	申报
May 27, 2026	Yea Christopher CHIEF DEVELOPMENT OFFICER	Option	33,800	$7.07	$239K	263,718	Form 4
May 27, 2026	Yea Christopher CHIEF DEVELOPMENT OFFICER	Sale	33,800	$26.78	$905K	229,918	Form 4
May 22, 2026	Yea Christopher CHIEF DEVELOPMENT OFFICER	Option	3,125	—	—	231,884	Form 4
May 26, 2026	Yea Christopher CHIEF DEVELOPMENT OFFICER	Sale	1,966	$26.78	$53K	229,918	Form 4
May 22, 2026	Sweeny Nicole Chief Commercial Officer	Option	5,000	—	—	60,780	Form 4
May 26, 2026	Sweeny Nicole Chief Commercial Officer	Sale	1,489	$26.78	$40K	59,291	Form 4
May 22, 2026	Audhya Paul K. CHIEF MEDICAL OFFICER	Option	5,000	—	—	152,499	Form 4
May 26, 2026	Audhya Paul K. CHIEF MEDICAL OFFICER	Sale	2,239	$26.78	$60K	150,260	Form 4
May 21, 2026	Palleiko Benjamin L CHIEF EXECUTIVE OFFICER · Director	Option	23,250	—	—	490,915	Form 4
May 22, 2026	Palleiko Benjamin L CHIEF EXECUTIVE OFFICER · Director	Sale	10,926	$26.78	$293K	479,989	Form 4
May 21, 2026	Sweeny Nicole Chief Commercial Officer	Option	6,250	—	—	57,641	Form 4
May 22, 2026	Sweeny Nicole Chief Commercial Officer	Sale	1,861	$26.78	$50K	55,780	Form 4
May 21, 2026	Yea Christopher CHIEF DEVELOPMENT OFFICER	Option	3,750	—	—	231,117	Form 4
May 22, 2026	Yea Christopher CHIEF DEVELOPMENT OFFICER	Sale	2,358	$26.78	$63K	228,759	Form 4
May 21, 2026	Audhya Paul K. CHIEF MEDICAL OFFICER	Option	6,250	—	—	150,184	Form 4
May 22, 2026	Audhya Paul K. CHIEF MEDICAL OFFICER	Sale	2,685	$26.78	$72K	147,499	Form 4
May 21, 2026	Piekos Brian CFO	Option	5,000	—	—	23,150	Form 4
May 22, 2026	Piekos Brian CFO	Sale	1,489	$26.78	$40K	21,661	Form 4
May 17, 2026	Yea Christopher CHIEF DEVELOPMENT OFFICER	Option	1,774	—	—	228,475	Form 4
May 18, 2026	Yea Christopher CHIEF DEVELOPMENT OFFICER	Sale	1,108	$26.76	$30K	227,367	Form 4
May 17, 2026	Audhya Paul K. CHIEF MEDICAL OFFICER	Option	2,419	—	—	144,966	Form 4
May 18, 2026	Audhya Paul K. CHIEF MEDICAL OFFICER	Sale	1,032	$26.76	$28K	143,934	Form 4
May 17, 2026	Palleiko Benjamin L CHIEF EXECUTIVE OFFICER · Director	Option	2,419	—	—	468,794	Form 4
May 18, 2026	Palleiko Benjamin L CHIEF EXECUTIVE OFFICER · Director	Sale	1,129	$26.76	$30K	467,665	Form 4
May 11, 2026	Palleiko Benjamin L CHIEF EXECUTIVE OFFICER · Director	Option	7,120	—	—	469,697	Form 4

Yea Christopher

CHIEF DEVELOPMENT OFFICER

Option

日期

May 27

股数

33,800

均价

$7.07

总金额

$239K

View Form 4 on SEC.gov

Yea Christopher

CHIEF DEVELOPMENT OFFICER

Sale

日期

May 27

股数

33,800

均价

$26.78

总金额

$905K

View Form 4 on SEC.gov

Yea Christopher

CHIEF DEVELOPMENT OFFICER

Option

日期

May 22

股数

3,125

均价

—

总金额

—

View Form 4 on SEC.gov

Yea Christopher

CHIEF DEVELOPMENT OFFICER

Sale

日期

May 26

股数

1,966

均价

$26.78

总金额

$53K

View Form 4 on SEC.gov

Sweeny Nicole

Chief Commercial Officer

Option

日期

May 22

股数

5,000

均价

—

总金额

—

View Form 4 on SEC.gov

Sweeny Nicole

Chief Commercial Officer

Sale

日期

May 26

股数

1,489

均价

$26.78

总金额

$40K

View Form 4 on SEC.gov

Audhya Paul K.

CHIEF MEDICAL OFFICER

Option

日期

May 22

股数

5,000

均价

—

总金额

—

View Form 4 on SEC.gov

Audhya Paul K.

CHIEF MEDICAL OFFICER

Sale

日期

May 26

股数

2,239

均价

$26.78

总金额

$60K

View Form 4 on SEC.gov

Palleiko Benjamin L

CHIEF EXECUTIVE OFFICER · Director

Option

日期

May 21

股数

23,250

均价

—

总金额

—

View Form 4 on SEC.gov

Palleiko Benjamin L

CHIEF EXECUTIVE OFFICER · Director

Sale

日期

May 22

股数

10,926

均价

$26.78

总金额

$293K

View Form 4 on SEC.gov

Sweeny Nicole

Chief Commercial Officer

Option

日期

May 21

股数

6,250

均价

—

总金额

—

View Form 4 on SEC.gov

Sweeny Nicole

Chief Commercial Officer

Sale

日期

May 22

股数

1,861

均价

$26.78

总金额

$50K

View Form 4 on SEC.gov

Yea Christopher

CHIEF DEVELOPMENT OFFICER

Option

日期

May 21

股数

3,750

均价

—

总金额

—

View Form 4 on SEC.gov

Yea Christopher

CHIEF DEVELOPMENT OFFICER

Sale

日期

May 22

股数

2,358

均价

$26.78

总金额

$63K

View Form 4 on SEC.gov

Audhya Paul K.

CHIEF MEDICAL OFFICER

Option

日期

May 21

股数

6,250

均价

—

总金额

—

View Form 4 on SEC.gov

Audhya Paul K.

CHIEF MEDICAL OFFICER

Sale

日期

May 22

股数

2,685

均价

$26.78

总金额

$72K

View Form 4 on SEC.gov

Piekos Brian

CFO

Option

日期

May 21

股数

5,000

均价

—

总金额

—

View Form 4 on SEC.gov

Piekos Brian

CFO

Sale

日期

May 22

股数

1,489

均价

$26.78

总金额

$40K

View Form 4 on SEC.gov

Yea Christopher

CHIEF DEVELOPMENT OFFICER

Option

日期

May 17

股数

1,774

均价

—

总金额

—

View Form 4 on SEC.gov

Yea Christopher

CHIEF DEVELOPMENT OFFICER

Sale

日期

May 18

股数

1,108

均价

$26.76

总金额

$30K

View Form 4 on SEC.gov

Audhya Paul K.

CHIEF MEDICAL OFFICER

Option

日期

May 17

股数

2,419

均价

—

总金额

—

View Form 4 on SEC.gov

Audhya Paul K.

CHIEF MEDICAL OFFICER

Sale

日期

May 18

股数

1,032

均价

$26.76

总金额

$28K

View Form 4 on SEC.gov

Palleiko Benjamin L

CHIEF EXECUTIVE OFFICER · Director

Option

日期

May 17

股数

2,419

均价

—

总金额

—

View Form 4 on SEC.gov

Palleiko Benjamin L

CHIEF EXECUTIVE OFFICER · Director

Sale

日期

May 18

股数

1,129

均价

$26.76

总金额

$30K

View Form 4 on SEC.gov

Palleiko Benjamin L

CHIEF EXECUTIVE OFFICER · Director

Option

日期

May 11

股数

7,120

均价

—

总金额

—

View Form 4 on SEC.gov

⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股

1 / 3

▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —

关于 KALV 内幕交易

KALV 内幕交易

KalVista Pharmaceuticals, Inc.（KALV）内幕交易数据来源于公司内部人（包括Palleiko Benjamin L (CHIEF EXECUTIVE OFFICER · Director), Yea Christopher (CHIEF DEVELOPMENT OFFICER), Audhya Paul K. (CHIEF MEDICAL OFFICER)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。KALV内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。

如需查看KalVista Pharmaceuticals, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →

买卖信号逻辑

acquisitionOrDisposition字段：

A = 买入 · D = 卖出（处置）

RSU归属（M-Exempt）不计入情绪判断

Form 4SEC要求内部人在任何交易后2个工作日内提交的申报文件

10b5-1预设交易计划，允许内部人按计划自动卖出

Open Mkt公开市场直接买卖（不含股权奖励和期权行权）

机构持仓 SEC 申报财务报表价格历史预测与评级财报

常见问题

KALV 内幕交易 · 5个问题

KalVista Pharmaceuticals, Inc.（KALV）的内部人包括高管和董事，如Palleiko Benjamin L (CHIEF EXECUTIVE OFFICER · Director), Yea Christopher (CHIEF DEVELOPMENT OFFICER), Audhya Paul K. (CHIEF MEDICAL OFFICER)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。

KALV 董事内幕交易KALV 内部人名单KalVista Pharmaceuticals, Inc. 高管内幕活动

▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026